Event to be held via webcast on March 25, 2025 at 4:00 p.m. ET To highlight differentiated drug discovery capabilities with ...

Harpenden and Berkhamsted’s MP, Victoria Collins, has organised a coffee morning on the 27th March at 11:00AM in Central ...

The NHS has teamed up with the Dianne Oxberry Trust and Target Ovarian Cancer to bring a new awareness roadshow to the streets of Greater Manchester – including Wigan and Leigh – this March for ...

A woman whose mother died five years after a cancer misdiagnosis is calling for second opinions on oncology scans to be made ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Rachael Misfud, 38, was diagnosed with cancer nine months after being waitlisted for what was thought to be a benign cyst ...

A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

A major biotech breakthrough is happening in New Orleans. Beken Bio, a biotech startup company that is soon to be based at ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...